Internalization of herpes simplex virus type 1 (HSV) KOS strain by HEp-2 cells was reversibly inhibited by pretreatment of cells with cytochalasins B and D. Internalization of virus following preincubation at 4 °C and temperature shift to 37 °C was normally preceded by a 5 to 8 min lag period and was complete within 20 to 30 min. A similar lag period followed HSV addition at 37 °C. Cytochalasin D was fivefold more active on HSV entry than cytochalasin B, with 50~ inhibition at 2 ~tM and 10 ~tM respectively. Inhibition was completely reversible, such that all cell-bound infectious virus was recovered upon removal of cytochalasin. In conjunction with previous reports, the activity of cytochalasin on HSV entry suggests that a change in cytoskeletal structure following virus attachment triggers a microfilament activity important for internalization of HSV by HEp-2 cells.
Inhibition of Herpes Simplex

SUMMARY
Internalization of herpes simplex virus type 1 (HSV) KOS strain by HEp-2 cells was reversibly inhibited by pretreatment of cells with cytochalasins B and D. Internalization of virus following preincubation at 4 °C and temperature shift to 37 °C was normally preceded by a 5 to 8 min lag period and was complete within 20 to 30 min. A similar lag period followed HSV addition at 37 °C. Cytochalasin D was fivefold more active on HSV entry than cytochalasin B, with 50~ inhibition at 2 ~tM and 10 ~tM respectively. Inhibition was completely reversible, such that all cell-bound infectious virus was recovered upon removal of cytochalasin. In conjunction with previous reports, the activity of cytochalasin on HSV entry suggests that a change in cytoskeletal structure following virus attachment triggers a microfilament activity important for internalization of HSV by HEp-2 cells.
The involvement of the cytoskeleton in herpes simplex virus type 1 (HSV-1) attachment and penetration was suggested by fluorescence photobleaching recovery measurements (Rosenthal et al., 1984) . An initial limitation of cell surface protein mobility, characteristic of anchorage modulation of cell surface protein mobility was observed. This is mediated by multivalent ligand crosslinking of cell surface proteins interacting with the cytoskeleton (Gall & Edelman, 1981) . The anchorage modulation was released concurrent with initiation of virus penetration with a return to control levels following completion of virus internalization.
These results suggest that cytoskeletal function is involved in HSV penetration into the target cell. The microfilament component of the cytoskeleton is important for contractile processes involved in motility, capping, phagocytosis and cell surface protein movement (Tanenbaum, 1978) but not in uptake by clathrin-coated vesicles. The role of the microfilaments in HSV entry into the target cell was investigated using the selective inhibitors cytochalasin B (CB) and D (CD). The cytochalasins bind to actin, preventing its proper polymerization into microfilaments (MacLean-Fletcher & Pollard, 1980) . CB has been shown to partially inhibit the penetration of other enveloped viruses such as vesicular stomatitis and Sindbis viruses (Coombs et al., 1981) but not influenza (Patterson et al., 1979) or Sendal viruses. However, Sendal virus-induced cellcell fusion is inhibited by CB (Asano & Okada, 1977; Miyake et al., 1978) .
Recently, Lycke et al. (1984) have shown that CB and CD inhibit the axoplasmic transport of HSV in neurons, indicating the role of microfilaments in transporting virion capsids within the cytoplasm. In this study we show that cytochalasins also inhibit the internalization of HSV into the cell.
Stocks of HSV-1 (KOS strain, originally provided by P. Schaffer, Dana Farber Cancer Institute, Boston, Mass., U.S.A.) were prepared by low multiplicity infection of HEp-2 cells (0.01 p.f.u./cell) and infectivity was evaluated by plaque assay on Vero cells using a 1.5~ methyl cellulose overlay (Dreesman & Benyesh-Melnick, 1967) . Cells were maintained in Eagle's MEM (Auto-Pow; Flow Laboratories) supplemented with foetal calf serum (10~) and antibiotics (penicillin G, 25 U/ml; L-glutamine, 29-2 ~tg/ml; gentamicin 50 ~tg/ml). Maintenance 0000-6553 © 1985 SGM medium was supplemented with 2~ newborn calf serum instead of foetal calf serum. Trisbuffered saline (TBS) consisted of 10 mM-Tris-HC1 pH 7-4 and 150 mM-NaC1; PBS is Dulbecco's phosphate-buffered saline.
The penetration of HSV into HEp-2 cells grown in 24-well tissue culture plates (Corning) was assayed by protection from acid inactivation of internalized virus (Rosenthal et al., 1984) as modified from Huang & Wagner (1964) . Basically, HEp-2 cells were infected at 4 °C with approximately 104 p.f.u, of HSV-1 and maintained at 4 °C for 4 h to allow attachment of the virus. The cells were then washed three times with PBS pH 7-4, and preincubated with the appropriate treatment in 0.3 ml PBS for 20 min at 4 °C. The temperature was rapidly increased by transfer of the 24-well plate to a 37 °C water-bath. Before, and at various times after the temperature increase, 1 ml of PBS pH 3-0, was added to the wells, removed after 1 min and the cells were washed at least three times with maintenance medium to remove the cytochalasin. Acid treatment of infected cells prior to temperature shift was an internal control for the inhibition of HSV entry at 4 °C. At the end of the experiment, all cell monolayers were washed with sterile PBS prior to overlay with methyl cellulose-containing maintenance medium for plaque assay. Using this procedure, the difference in plaque count between identically treated wells of a 24-well plate is less than 10~. For some experiments, virus was added to cells at 37 °C rather than at 4 °C.
CB or CD (Sigma) was added in ethanol solution to cells 15 min prior to shifting the cells from 4°C to 37 °C. The final ethanol concentration never exceeded 5~ and ethanol at this concentration had no effect on virus penetration or cell viability. In order to establish the reversibility of the inhibition, infected cell cultures treated identically to those described above were incubated for the same 20 rain period at 37 °C, washed free of inhibitor and then incubated for an additional 20 rain at 37 °C prior to acid inactivation of extracellular virus and plaque assay. Recovery of control levels of virus infection also indicated that the virus remained bound to the cell and viable during the treatment period.
Upon addition of HSV to HEp-2 cell monolayers maintained at 37 °C, cellular protection of virus occurred following a 5 min lag period and continued for at least 30 min (Fig. 1) . Protection from acid inactivation upon temperature shift from 4 to 37 °C of HSV prebound to HEp-2 cells was also observed after a 5 min lag period followed immediately by a maximum rate of penetration and completion within 20 to 30 min. A similar lag period prior to internalization of HSV-1 was observed by protection of fluoresceinated HSV from light inactivation (DeLuca et al., 1981) . These kinetics are similar to those observed for the changes in cytoskeletal structure and function as determined by fluorescence photobleaching recovery measurements (Rosenthal et al., 1984) .
As shown in Fig. 2 , CB and CD inhibited the internalization of HSV into HEp-2 cells. Reduction in virus penetration was observed at cytochalasin concentrations greater than 1 ~tM (Fig. 2) . However, no effect on HSV penetration could be observed if the inhibitor was added to cells maintained at 37 °C and then infected. The inhibition of HSV penetration into HEp-2 cells showed a non-linear dependence on cytochalasin concentration suggestive of a biphasic concentration response. A clear minimum inhibitory concentration for virus penetration could not be obtained. However, 50~ inhibition was observed at 2 ~tM-CD and 10 ~M-CB. A fivefold greater activity of CD over CB was observed throughout the concentration range tested, as has also been observed for other systems (Tanenbaum, 1978) . Neither CB nor CD had a direct effect on the infectivity of HSV when incubated with the virus for 30 min at 37 °C prior to dilution and plaque assay. Fig. 3 shows the kinetics of HSV penetration into cells treated with 70 jtM-CB or untreated. Virus penetration was significantly but not totally inhibited. Inhibition was observed for the entire incubation period, at least 40 min. Longer incubation periods with this concentration of CB were detrimental to the cells and could not be used. The reversibility of CB and CD inhibition of HSV internalization was determined by washing the compound from the cells after a 20 min treatment period followed by an additional 20 min incubation in the absence of the compound. As shown in Fig. 3 , for CB and as performed for each concentration of CB and CD tested in Fig. 2 , complete recovery of control levels of virus penetration followed removal of the Fig. 1 ), incubated for 15 min, shifted to 37 °C and incubated for 20 min. The monolayers were either treated with PBS pH 3.0 to inactivate extracellular virus or washed and incubated for 20 more min at 37 °C prior to acid treatment and plaque assay (data not shown).
drug. This was equivalent to the number of plaques obtained if no acid had been added to an uninfected, untreated monolayer.
The time of addition of cytochalasin B (70 ~tM) was varied with respect to HSV replication and virus production was assayed to determine the effect of cytochalasins on steps in viral replication other than penetration. No inhibition of HSV production was observed following a 30 to 60 min treatment period with CB at any time other than during the virus penetration period.
The role of microfilaments in HSV penetration is indicated by the inhibition of HSV penetration by both cytochalasins B and D. As for other biological systems (Tanenbaum, 1978) , this inhibition was completely reversible, expressed a non-linear concentration dependence suggestive of two binding curves and CD was fivefold more active than CB. Complete recovery of infectivity and virus penetration following removal of the inhibition is particularly significant in that it proves that the cytochalasin treatment used in these experiments does not kill the target cell, destroy the virus or cause elution of the virus from the cell. Hence, inhibition of a later step in HSV replication by CB (Dix & Courtney, 1976; Farber & Eberle, 1976) is not relevant to these results. Inhibition of HSV penetration by CD shows that other activities attributed to CB, e.g. inhibition of glucose transport, are similarly not relevant.
Enhancement of cytochalasin activity on HSV entry by prior incubation of the cells at 4 °C suggests that dissociation of microfilaments into actin monomers at 4 °C may potentiate the binding of the compound to actin (MacLean-Fletcher & Pollard, 1980) preventing microfilament reassociation even at 37 °C. Alternatively, the low-temperature conditions with cytochalasin might prevent the re-establishment of microtubule-microfilament interactions (Yahara & Edelman, 1975 ) required for HSV penetration at 37 °C following the temperature shift. Inhibition of the penetration of other viruses by cytochalasins (Coombs et al., 1981; Patterson & Russell, 1983; Epstein et al., 1983 ) most likely also requires prior incubation at 4 °C.
The role of the microtubule component of the cytoskeleton in HSV penetration is more difficult to discern. Inhibitors of microtubule function, colchicine and vinblastine, were tested but no effect on penetration alone could be discerned due to the toxicity and limited reversibility of these compounds (data not shown). In another study, HSV infection occurred despite demicolchicine disruption or taxol stabilization of microtubules (Norrild et al., 1983) .
Our results from this and previous papers suggest that multivalent attachment of HSV to its receptors on HEp-2 cells triggers a capping or phagocytosis-like activity which utilizes microfilament activity to bring the lipid domains of the viral envelope and plasma membrane into close apposition. Fusion and virus penetration is then promoted by a viral glycoprotein, most likely gB for HSV (Sarmiento et al., 1979) . As suggested for Epstein-Barr virus, the actual mechanism of HSV entry may be a function of both the individual viral and cellular characteristics (Nemerow & Cooper, 1984) .
